Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2012
05/16/2012CN1968712B Novel antigen-binding polypeptides and their uses
05/16/2012CN1863556B Compositions and methods for treating coagulation related disorders
05/16/2012CN1842600B A process for proteolytic cleavage and purification of recombinant proteins
05/16/2012CN102459628A Anti-human cd52 immunoglobulins
05/16/2012CN102459627A 通过酰基-辅酶A溶血磷脂酰基转移酶的表达对长链ω-3和ω-6多不饱和脂肪酸的生物合成的改善 By acyl - coenzyme A lysophospholipid acyltransferase expression of long-chain ω-3 and ω-6 redundant creature improved synthesis of unsaturated fatty acids
05/16/2012CN102459608A 组合工程 Integrated Engineering
05/16/2012CN102459603A Fucosylation-deficient cells
05/16/2012CN102459586A Expression vector for establishing hyper-producing cells, and hyper-producing cells
05/16/2012CN102459570A Zymomonas with improved arabinose utilization
05/16/2012CN102459346A Method for making heteromultimeric molecules
05/16/2012CN102459342A Anti-il-3ra antibody for use in treatment of blood tumor
05/16/2012CN102459317A 用于crm197及其衍生物的生产的人工基因的细菌表达 Crm197 bacterial expression and its derivatives for the production of artificial genes
05/16/2012CN102458617A 层叠的转基因蛋白质的多重分析 Multi-layered analysis of transgenic protein
05/16/2012CN102458469A Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
05/16/2012CN102458468A Anti-cd100 antibodies and methods for using the same
05/16/2012CN102458459A 双重可变结构域免疫球蛋白及其用途 Dual variable domain immunoglobulins and their use
05/16/2012CN102453741A Method for preparing high-activity corn antihypertensive peptide and special device
05/16/2012CN102453711A Establishment of protein secreted expression vector and application of same
05/16/2012CN102453108A Combined production method for processing chondroitin sulfate and protein powder with bird skeletons as raw material
05/16/2012CN102453077A Novel fluoronosiheptide and preparation method and application thereof
05/16/2012CN101899410B Streptomyces parvus and application thereof for preparing daptomycin
05/16/2012CN101696243B Human genetic engineering antibody TRD 109 as well as preparation method and application thereof
05/16/2012CN101306019B Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
05/16/2012CN101255431B Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/15/2012US8178346 GPCR expression vector
05/15/2012US8178339 Reduced genome E. coli
05/15/2012US8178337 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
05/15/2012US8178336 Polypeptide
05/15/2012US8178335 Intracellular production of a nuclease
05/15/2012US8178328 Fermentive production of four carbon alcohols
05/15/2012US8178324 Deracemisation of amines
05/15/2012US8178320 Artificial antibody library with super-repertory
05/15/2012US8178319 Peptides and uses thereof
05/15/2012US8178318 Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield
05/15/2012US8178317 Compositions and methods for identifying transforming and tumor suppressor genes
05/15/2012US8178316 Evaluating proteins
05/15/2012US8178310 Babesia microti genomic clones containing novel antigens useful in the diagnosis of Babesios
05/15/2012US8178298 Patched polypeptides and uses related thereto
05/15/2012US8178101 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
05/15/2012US8178093 Method for treating infectious disease using monoclonal antibodies
05/15/2012US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2505705C Compositions and methods for the diagnosis and treatment of tumor
05/15/2012CA2465891C Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2434237C Glp-1 fusion proteins
05/15/2012CA2409940C Anti-listeria bacteriocin
05/15/2012CA2335098C Protease susceptibility ii
05/15/2012CA2272842C Humanized anti-cd11a antibodies
05/10/2012WO2012061776A1 Methods for producing virus particles with simplified glycosylation of surface proteins
05/10/2012WO2012061637A2 Hsv-1 epitopes and methods for using same
05/10/2012WO2012059715A1 Expression process
05/10/2012WO2012026309A9 Creation of anti-pad4 antibody pharmaceutical
05/10/2012WO2012018767A3 Antibodies directed against il-17
05/10/2012US20120117670 Humanized axl antibodies
05/10/2012US20120117669 Human antibodies derived from immunized xenomice
05/10/2012US20120116057 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering
05/10/2012US20120116056 Fc fusion proteins of human growth hormone
05/10/2012US20120116053 Expression of triple-helical collagen-like products in e.coli
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115775 Mutant tat proteins and uses thereof
05/10/2012US20120115741 Reagents For The Atherosclerotic Coronary Plaque And Uses Thereof
05/10/2012US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
05/10/2012US20120115187 Production Of Recombinant Proteins Utilizing Non-Antibiotic Selection Methods And The Incorporation Of Non-Natural Amino Acids Therein
05/10/2012US20120115156 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
05/10/2012US20120115151 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta
05/10/2012US20120114797 Talaromyces strains and enzyme compositions
05/10/2012US20120114776 Methods for preparing probiotic nanoparticles
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114686 Compositions and methods related to protein a (spa) variants
05/10/2012US20120114672 Antibodies Specific to Cadherin-17
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114665 Human antibodies to human rankl
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114652 Anti-pai-1 antibodies and methods of use thereof
05/10/2012US20120114650 Single chain antibodies against beta-amyloid peptide
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114613 Definitive endoderm cell populations
05/10/2012US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
05/10/2012CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins
05/09/2012EP2450364A1 Process for production of peptide thioester
05/09/2012EP2450056A1 Prevention and treatment of synucleinopathic and amyloidogenic disease
05/09/2012EP2449127A2 Polypeptides and method of treatment
05/09/2012EP2449126A1 Novel antibodies and their uses in therapeutic and diagnostic methods
05/09/2012EP2449101A1 Neurotoxins exhibiting shortened biological activity
05/09/2012EP2449098A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
05/09/2012EP2267024B1 Production of recombinant Il-18 binding protein
05/09/2012EP1733041B1 Anti-myostatin antibodies
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/09/2012EP1496110B1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
05/09/2012CN102449160A Process for production of useful substance, and surfactant for use in the process
05/09/2012CN102448494A Immunoconjugates with an intracellularly-cleavable linkage
05/09/2012CN102448486A Antibody drug conjugates (ADC) that bind to 24p4c12 proteins
05/09/2012CN102443618A Method for generating polypeptide by enzymolysis of oyster extract
05/09/2012CN102443617A Preparation method for garlic blood pressure-lowering functional factor through ultrasound-assisted enzymatic hydrolysis
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application